Farms.com Home   News

USDA Announces Commodity Credit Corporation Lending Rates For May 2016

The U.S. Department of Agriculture's Commodity Credit Corporation (CCC) today announced interest rates for May 2016. The CCC borrowing rate-based charge for May is 0.625 percent, unchanged from 0.625 percent in April.

The interest rate for crop year commodity loans less than one year disbursed during May is 1.625 percent, unchanged from 1.625 percent in April.

Interest rates for Farm Storage Facility Loans approved for May are as follows, 0.875 percent with three-year loan terms, 1.250 percent with five-year loan terms, 1.625 percent with seven-year loan terms, unchanged from 1.625 percent in April; 1.750 percent with 10-year loan terms, down from 1.875 percent in April and; 1.875 percent with 12-year loan terms, down from 2.000 percent in April. The interest rate for 15-year Sugar Storage Facility Loans for May is 2.000 percent, down from 2.125 percent in April.

Source:usda.gov


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.